We can offer a discount on bulk orders. Please contact our sales team for further inquiry.
Product Infomation
Product Name Rosiglitazone-lipid nanoparticle-CGKRK targeting peptide complex
Catalog Number LNP-049
Size 10 mg; 25 mg; 50 mg
Alias Rosiglitazone@LNP-CGKRK; Rosiglitazone@LNP-peptide
Appearance Milky white or transparent colloidal solution
Solubility Soluble in organic solvents
Description Rosiglitazone@LNP-CGKRK peptide is an innovative drug delivery complex that combines the research advantages of rosiglitazone with the delivery capabilities of LNP and the targeting properties of CGKRK peptide. Rosiglitazone, a thiazolidinedione drug, can increase insulin sensitivity by activating peroxisome proliferator-activated receptor γ (PPARγ)and effectively assist in controlling blood sugar levels in research models with type 2 diabetes. Lipid nanoparticles (LNP)are composed of ionizable cationic lipids, phospholipids, cholesterol and PEGylated lipids, which can stably encapsulate rosiglitazone, protect it from degradation, prolong the circulation time of the drug in the body, and enhance drug stability.
Applications Targeted antitumor research
Storage -20°C, protected from light
Purity 95%+
Shelf Life 1 Year
Shipping Condition Low temperature transport
Online Inquiry
For Research or Industrial Raw Materials, Not For Personal Medical Use!
Copyright © MATEXCEL. All Rights Reserved.
0
Inquiry Basket